Transcript
There are a number of different kinds of lung cancer. 

One would be non-small cell lung cancer. 

Another would be small cell lung cancer. Small cell lung cancer is a faster growing, more aggressive type of lung cancer. 

When I explain to patients our treatment options, specifically toward non-small cell lung cancer, I often explain we have oral medications. 

Immunotherapy is an infusion. It helps cells within your body, that are already trying to attack your lung cancer, do a better job of attacking your lung cancer. 

And then a third option that we do still use quite a bit is chemotherapy. Often, we use chemotherapy in combination with another type of medicine, most likely immunotherapy. This combination of chemotherapy and immunotherapy leads to significantly improved survival, long-term survival for patients, which is ultimately our goal.  

A newer type of medicine that we're just now starting to use more of, and I think we'll be using more of in the future, are medicines that are called antibody-drug conjugates. The way I describe it is thereีs, essentially, a missile, which is an antibody that brings a small
warhead to the tumor. 

So that's a really promising option, right now, only a few people with lung cancer, but that might be more of an option in the future.